APA (7th ed.) Citation

Langabeer, S., Haslam, K., Crampe, M., MacDonagh, B., & McHugh, J. (2023). Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia. PH Akademperiodyka.

Chicago Style (17th ed.) Citation

Langabeer, S.E, K. Haslam, M. Crampe, B. MacDonagh, and J. McHugh. Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated with Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia. PH Akademperiodyka, 2023.

MLA (8th ed.) Citation

Langabeer, S.E, et al. Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated with Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia. PH Akademperiodyka, 2023.